IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Positive IHL-675A in vivo results and FDA Pathway, page-83

  1. 656 Posts.
    lightbulb Created with Sketch. 285
    i think youre spot on with that. The efficacy shown in that time period alone is remarkable. Saards in itself is quite aggresive in its ability to cause serious damage in a short period of time so this was a great result to show that ihl-675a can combat it rapidly.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.